Report Overview:
Neurological disorder diagnostic tools are essential instruments used for diagnosing a variety of neurological conditions. These disorders, which affect the brain, spinal cord, and nervous system, include diseases such as Alzheimer's, Parkinson’s disease, multiple sclerosis, epilepsy, and other neurological impairments. Diagnostic tools help identify the presence, severity, and type of neurological disorder, enabling timely treatment and management. These tools range from imaging techniques like MRI, CT scans, and PET scans, to in vitro diagnostic (IVD) tools, such as blood tests and genetic analysis. Accurate diagnosis is crucial for managing symptoms, predicting disease progression, and formulating effective treatment plans.
Market Value:
The global neurological disorder diagnostics market has shown remarkable growth and is projected to continue on its upward trajectory. In 2024, the market was valued at approximately USD 10.08 billion and is expected to reach USD 14.47 billion by 2032, reflecting a compound annual growth rate (CAGR) of 4.10%. CAGR of 4.10% (2025 – 2032)
By Types:
• Imaging Techniques • In Vitro Diagnostics Techniques
By Applications: Hospitals and Clinics
Diagnostic Centers
Ambulatory Care Centers
Key players include:
• Siemens
• Philips
• GE
• Esaote
• Masimo
• Croton Healthcare
• Neusoft
• Including or Excluding key companies relevant to your analysis.
